Switch to:
More From Other Websites
Anacor's Kerydin Launched in the US for Onychomycosis Sep 23 2014
ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 22 2014
Anacor Pharmaceuticals Announces Commercial Launch of KERYDIN (tavaborole) Topical Solution, 5% in... Sep 22 2014
The Zacks Analyst Blog Highlights: Merck KGaA, Lannett, Avanir Pharmaceuticals, Anacor... Sep 16 2014
ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Sep 12 2014
Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors Sep 12 2014
Anacor Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Sep 03 2014
ANACOR PHARMACEUTICALS, INC. Financials Aug 19 2014
Rigel's R348 Fails in Phase II Study, Shares Down 13.6% Aug 14 2014
Anacor (ANAC) Shares March Higher, Can It Continue? Aug 13 2014
AVEO Pharmaceuticals Posts Narrower-than-Expected Q2 Loss Aug 13 2014
Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus Aug 12 2014
Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance Aug 12 2014
ARIAD Falls on Wider-than-Expected Loss, Revenues Miss Aug 11 2014
ANACOR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2014
Anacor Pharmaceuticals Reports Second Quarter 2014 Financial Results Aug 07 2014
Anacor Pharmaceuticals to Present at Upcoming Investor Conferences Aug 07 2014
Q2 2014 Anacor Pharmaceuticals Inc Earnings Release - After Market Close Aug 07 2014
Should You Buy Anacor Pharmaceuticals (ANAC) Ahead of Earnings? Aug 06 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK